%20scale(0.100000,-0.100000)'%20fill='%23000000'%20stroke='none'%3e%3cpath%20d='M3195%205489%20c-380%20-49%20-706%20-317%20-831%20-682%20-56%20-163%20-54%20-112%20-54%20-1773%20l0%20-1534%20590%200%20590%200%200%201465%200%201465%20600%200%20600%200%200%20535%200%20535%20-712%20-1%20c-392%20-1%20-744%20-6%20-783%20-10z'/%3e%3c/g%3e%3c/svg%3e)
| Mayukh Sukhatme | President and Chief Investment Officer | FY2024 | |
| Matthew Gline | Chief Executive Officer | FY2024 | |
| Eric Venker | President and Immunovant CEO | FY2024 | |
| Rakhi Kumar | Former Chief Accounting Officer | FY2024 | |
| Richard Pulik | Chief Financial Officer | FY2024 | |
| Jennifer Humes | Chief Accounting Officer | FY2024 |
6 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.